{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:37:14Z","timestamp":1791434234733,"version":"4.3.3"},"reference-count":32,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["10.13039\/100009945"],"award-info":[{"award-number":["10.13039\/100009945"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,9,27]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence on relapse activity in relapsing-remitting multiple sclerosis (RRMS) after assisted reproductive technology (ART) treatment differs. We investigated whether relapse activity increased after ART initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Women with RRMS from the Danish MS Registry who underwent ART treatment from 1995 to 2018 were eligible. The annualised relapse rate (ARR) and corresponding 95%\u2009CI at 3 and 9\u2009months post-ART initiation versus 12 months pre-ART were investigated using a negative binomial regression model. Analyses were stratified for live births within 12 months post-ART and disease-modifying therapy (DMT) use pre-ART. Clinical and demographic factors associated with relapse risk were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At ART initiation, 162\u2009women, median age 33 years (IQR: 30\u201337), median Expanded Disability Status Scale score 1.5 (IQR: 1.0\u20132.5) were included; 55 (34.0%) were exposed to DMT. 27 relapses were recorded (ARR (95%\u2009CI) 0.17 (0.11 to 0.26)) at 12 months pre-ART; 7 relapses and 0.17 (0.08 to 0.36) at 3\u2009months post-ART initiation, and 16 relapses and 0.13 (0.08 to 0.23) at 9\u2009months post-ART initiation. When stratified by ART outcomes, relapse counts in subgroups became small. Women continuing DMT at ART initiation showed a statistically non-significant increase in ARR at 3\u2009months post-ART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women with RRMS in Denmark did not, on average, have increased relapse activity at 3 and 9\u2009months post-ART initiation compared with 12 months pre-ART. Women with disease activity pre-ART initiation may have a potentially elevated relapse risk post-ART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336080","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:20:35Z","timestamp":1760980835000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Relapse activity after assisted reproductive technology treatments in women with multiple sclerosis: a nationwide cohort study in Denmark"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-6457","authenticated-orcid":false,"given":"Lene","family":"von Kappelgaard","sequence":"first","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-3954","authenticated-orcid":false,"given":"Elisabeth","family":"Framke","sequence":"additional","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"Vassard","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital \u2013 Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital \u2013 Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Enrique","family":"Schwarze","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7201-4079","authenticated-orcid":false,"given":"Meritxell","family":"Sabid\u00f3","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-5222","authenticated-orcid":false,"given":"Melinda","family":"Magyari","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Danish Multiple Sclerosis Registry and Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"2025121202251621000_97.1.44.1","doi-asserted-by":"publisher","DOI":"10.1177\/135245852097084"},{"key":"2025121202251621000_97.1.44.2","unstructured":"Women living with multiple sclerosis New York. 2024. Available: https:\/\/www.nationalmssociety.org\/understanding-ms\/what-is-ms\/who-gets-ms\/women-with-ms"},{"key":"2025121202251621000_97.1.44.3","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.620772","article-title":"Family planning decision making in people with multiple sclerosis","volume":"12","author":"Bonavita","year":"2021","journal-title":"Front Neurol"},{"key":"2025121202251621000_97.1.44.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00426-4"},{"key":"2025121202251621000_97.1.44.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102541"},{"key":"2025121202251621000_97.1.44.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330883"},{"key":"2025121202251621000_97.1.44.7","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/1352458519851245","article-title":"Reproductive history of the Danish multiple sclerosis population: a register-based study","volume":"26","author":"Moberg","year":"2020","journal-title":"Mult Scler"},{"key":"2025121202251621000_97.1.44.8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40263-023-01036-1","article-title":"Assisted reproductive technology and disease management in infertile women with multiple sclerosis","volume":"37","author":"Sparaco","year":"2023","journal-title":"CNS Drugs"},{"key":"2025121202251621000_97.1.44.9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23745"},{"key":"2025121202251621000_97.1.44.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0607-2"},{"key":"2025121202251621000_97.1.44.11","doi-asserted-by":"publisher","DOI":"10.1159\/000177937"},{"key":"2025121202251621000_97.1.44.12","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/01.wnl.0000208521.10685.a6","article-title":"Increase in multiple sclerosis relapse rate following in vitro fertilization","volume":"66","author":"Laplaud","year":"2006","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251621000_97.1.44.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302235"},{"key":"2025121202251621000_97.1.44.14","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519865118"},{"key":"2025121202251621000_97.1.44.15","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200106","article-title":"Inflammatory activity after diverse fertility treatments: a multicenter analysis in the modern multiple sclerosis treatment era","volume":"10","author":"Graham","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025121202251621000_97.1.44.16","first-page":"e1916","article-title":"Assessing the risk of relapse requiring corticosteroids after in vitro fertilization in women with multiple sclerosis","volume":"99","author":"Mainguy","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251621000_97.1.44.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-024-01483-4","article-title":"Evaluation of ovarian reserve and the assisted reproductive technology (ART) cycles\u2019 outcome as well as the relapse rate within one year after ART in women with multiple sclerosis: a case-control study","volume":"17","author":"Arabipoor","year":"2024","journal-title":"J Ovarian Res"},{"key":"2025121202251621000_97.1.44.18","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1921","article-title":"The Danish Multiple Sclerosis Registry","volume":"11","author":"Magyari","year":"2021","journal-title":"Brain Behav"},{"key":"2025121202251621000_97.1.44.19","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810387965"},{"key":"2025121202251621000_97.1.44.20","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"2025121202251621000_97.1.44.21","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00742-8"},{"key":"2025121202251621000_97.1.44.22","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0356-1"},{"key":"2025121202251621000_97.1.44.23","first-page":"130","article-title":"Disease activity in multiple sclerosis patients after assisted reproductive technology","volume":"28","author":"Romero-Pinel","year":"2022","journal-title":"Mult Scler"},{"key":"2025121202251621000_97.1.44.24","doi-asserted-by":"crossref","unstructured":"Range N , Haben S , Thiel S , et al . The Impact of Disease-modifying Therapy on Relapse Risk in Women with Multiple Sclerosis Undergoing Assisted Reproductive Technologies (ART) (S7.005). Neurology (ECronicon) 2024;102. doi:10.1212\/WNL.0000000000206426","DOI":"10.1212\/WNL.0000000000206426"},{"key":"2025121202251621000_97.1.44.25","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1212\/WNL.0000000000202966","article-title":"Impact of assisted reproductive technologies (ART) on relapse risk in women with multiple sclerosis (S31.005)","volume":"100(17_suppl_2)","author":"Range","year":"2023","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251621000_97.1.44.26","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.766956","article-title":"Estimating risk of multiple sclerosis disease reactivation in pregnancy and postpartum: the VIPRiMS Score","volume":"12","author":"Bsteh","year":"2021","journal-title":"Front Neurol"},{"key":"2025121202251621000_97.1.44.27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/WCO.0000000000001275","article-title":"Pregnancy and reproductive health in women with multiple sclerosis: an update","volume":"37","author":"Houtchens","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"2025121202251621000_97.1.44.28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.fertnstert.2022.10.027","article-title":"Assisted reproductive technology treatment and risk of multiple sclerosis - a Danish cohort study","volume":"119","author":"Kopp","year":"2023","journal-title":"Fertil Steril"},{"key":"2025121202251621000_97.1.44.29","doi-asserted-by":"crossref","first-page":"105893","DOI":"10.1016\/j.msard.2024.105893","article-title":"Multiple sclerosis: pregnancy, fertility, and assisted reproductive technology-a review","volume":"92","author":"Oreja-Guevara","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2025121202251621000_97.1.44.30","doi-asserted-by":"publisher","DOI":"10.1177\/1756285616631897"},{"key":"2025121202251621000_97.1.44.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.04.003"},{"key":"2025121202251621000_97.1.44.32","first-page":"125","article-title":"Assisted reproductive technology treatments in women with multiple sclerosis and their effect on annualised relapse rate: a register-based Danish cohort study","volume":"30(3_suppl)","author":"Kappelgaard","year":"2024","journal-title":"Mult Scler"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:25:29Z","timestamp":1765535129000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,12]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/jnnp-2025-336080"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336080","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]}}}